Budget five buckets, not one. The medication or program fee, the clinician charge, any labs or monitoring, shipping and cold handling, and the time spent confirming that the seller is a licensed pharmacy. Which of those buckets exist at all depends on the supply channel, so pick the channel first and price it second.
The channel decides the shape of the budget, not just the size
Two people can pay a similar amount each month and have completely different budgets underneath. One pays a plan copay and nothing else because the visit sits under a separate benefit. Another pays a single bundled figure that already contains the prescribing relationship. A third pays a pharmacy cash rate, a separate telemedicine charge, and a shipping line.
That matters because most planning mistakes are structural rather than arithmetic. People compare a number from one channel against a number from another and conclude one is cheaper, when the two numbers are covering different sets of things. Listing the buckets before the numbers stops that.
Five buckets every monthly figure has to cover
The first is the product itself, whether that is a branded fill dispensed against a prescription or a preparation made by a compounding pharmacy. The second is the prescribing charge, which is sometimes invisible because it is bundled and sometimes billed as a visit.
The third is monitoring. Baseline labs, follow-up visits, and any workup a prescriber orders are real recurring costs even when they are not billed monthly, and spreading them across twelve months gives a truer figure. The fourth is logistics: refrigerated shipping, needles and sharps disposal where those are not included, and replacement of anything damaged in transit.
The fifth is the one that has no invoice, and it is covered below.
What each channel actually charges for
| Channel | Who sets the number | Buckets usually included | What can move it mid-year |
|---|---|---|---|
| Insurance at a retail counter | The plan, through formulary tier and benefit design | Product only | Deductible reset, formulary change, prior authorization expiry |
| Cash at a counter with a discount platform | The platform’s contracted rate at that specific chain | Product only | Rate changes, pharmacy contract changes, stock availability |
| Manufacturer direct self-pay | The manufacturer, published on its own channel | Product, sometimes shipping | Program terms, refill timing rules, eligibility conditions |
| Telehealth selling branded product | The service, layered on top of a pharmacy price | Product, prescribing, shipping | Membership terms, introductory period ending |
| Supervised compounded program | The practice, as a flat recurring figure | Product, prescribing, shipping | Strength changes, program terms, pharmacy sourcing |
Manufacturer direct channels are the newest column in that table. Eli Lilly operates LillyDirect for its own products and Novo Nordisk operates NovoCare for its own, and both sell to self-paying patients on published terms rather than through a plan. Discount platforms such as GoodRx and SingleCare sit in a different lane entirely: they are not insurance and not a pharmacy, they are a negotiated cash rate a counter agrees to honor.
Telehealth services occupy the last two rows depending on what they dispense. Ro and Hims and Hers route branded prescriptions through pharmacies, while practices including Henry Meds and FormBlends quote one recurring figure that covers the clinician relationship and a compounded preparation together. A bundled figure is easier to forecast, and it is a figure for something the FDA has not approved, which is a separate consideration from the budgeting one.
The bucket almost nobody budgets: checking that the seller is real
Searches built around the word cheap surface a supply tier that legitimate channels do not compete with, because the listings undercutting everything are frequently not legitimate pharmacies. The FDA has documented counterfeit Ozempic entering the US supply chain, has issued warning letters against illegally marketed semaglutide and tirzepatide, and has established an import alert covering GLP-1 active ingredients with quality concerns. It has also warned about products sold as research chemicals or as not for human consumption.
Verification costs nothing but time, and skipping it can cost the entire outlay. A legitimate seller names the dispensing pharmacy, that pharmacy holds a license you can confirm with the state board of pharmacy, and a prescription written by a clinician is required before anything ships. No legitimate US channel takes an order without a prescription, and personal importation from an unlicensed overseas seller is not a cheaper version of the same product.
Budget an hour for this once, at the start. It is the highest-return hour in the whole exercise.
Escalation and refill timing move the monthly number without any price change
The approved tirzepatide label covers multiple strengths, and a treatment plan typically does not stay at the starting one. Where a channel prices by strength, the monthly figure steps up on a schedule that has nothing to do with any price increase. Anyone forecasting from the first month is forecasting from the cheapest month.
Refill cadence does the same thing from the other direction. A dispensing fee is charged per fill rather than per month, and some channels discount an extended supply, so the same annual quantity produces different totals depending on how it is split. Ask how a channel handles a mid-cycle strength change before the change happens rather than after.
Turning a monthly figure into a twelve-month one
Multiply, then add the things that do not recur monthly: the initial visit, baseline labs, and any follow-up the prescriber schedules. Then stress-test the figure against the two events most likely to break it, which are a strength increase and a coverage change at the plan year boundary.
Forecasting is easier when a channel publishes its numbers up front rather than revealing them at checkout. Among self-pay telehealth options, providers such as Ro, Henry Meds, and HealthRX post a public Zepbound cost reference that a budget can be built against, while others quote only after an intake form is submitted. A channel that states its recurring figure, its shipping treatment, and its strength-change policy before any payment is one a twelve-month projection can actually rely on.
Durability belongs in the budget as well. Both the tirzepatide obesity trial program and the maintenance trial that followed it describe results tied to continued treatment, and withdrawal data on this drug class shows regain after stopping. A figure that can be sustained for a year is worth more than a lower figure that runs out in month four, and current obesity pharmacotherapy guidance treats these medications as long-term rather than episodic.
Frequently asked questions
Should labs be counted in a monthly medication budget?
Yes, spread across the year. Baseline and follow-up testing is a real recurring cost even when it arrives as one or two bills rather than twelve. Dividing the expected annual total by twelve gives a monthly figure that survives contact with the actual statements.
Do bundled telehealth prices include everything?
Not always. Some bundles cover the prescribing relationship, the preparation, and shipping. Others separate the initial visit or charge for strength changes. The only reliable method is asking for the inclusions in writing before the first payment rather than inferring them from a headline figure.
Is a listing well below every other channel worth investigating?
Investigate it, then almost certainly reject it. Legitimate channels have a floor set by real acquisition and dispensing costs. Prices far under that floor usually indicate an unlicensed seller, an unapproved product, or an active ingredient that is not what the label claims.
How much should be budgeted for shipping and supplies?
It depends entirely on channel. Manufacturer and telehealth channels often include refrigerated shipping in the quoted figure, while a retail fill involves no shipping but may involve separate purchases for sharps disposal. Confirm which items are included before assuming either.
Does a budget need a line for stopping?
It is worth thinking about. Trial data on this class shows weight regain after discontinuation, so a plan that ends abruptly at the point the budget breaks is a different outcome from a plan that continues. Building a sustainable figure is part of the clinical decision, not separate from it.
